CD8A and neoplasm: In HNSCC, CD8+ T cells that underwent clonal expansion during ICB treatment expressed elevated tissue-resident memory (CD103+ZNF683+) and cytotoxicity programs (GZMB+PD-1+CTLA-4+) and show tumor-specific recognition (53).